Penserra Capital Management LLC Tekla Life Sciences Investors Call Options Transaction History
Penserra Capital Management LLC
- $4.61 Billion
- Q3 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding HQL
# of Institutions
77Shares Held
9.73MCall Options Held
0Put Options Held
0-
Saba Capital Management, L.P. New York, NY3.43MShares$51.5 Million0.82% of portfolio
-
Morgan Stanley New York, NY490KShares$7.36 Million0.0% of portfolio
-
Karpus Management, Inc. Pittsford, NY469KShares$7.04 Million0.23% of portfolio
-
1607 Capital Partners, LLC Richmond, VA419KShares$6.3 Million0.53% of portfolio
-
Sit Investment Associates Inc Minneapolis, MN417KShares$6.26 Million0.14% of portfolio
About TEKLA LIFE SCIENCES INVESTORS
- Ticker HQL
- Exchange NYSE
- Sector Financial Services
- Industry Asset Management
- Description
- Tekla Life Sciences Investors is a closed-ended equity mutual fund launched and managed by Tekla Capital Management LLC. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the life sciences sector, including the biotechnology, pharmaceutical, diagnostics, managed healthcare, medical...